Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

During the pandemic, Matthew Memoli, who has conducted research on influenza and other viruses, was also a vocal critic of Anthony Fauci, who for decades served as the director of the National ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.

A memo from the NIH's acting director indicated research and clinical studies that began prior to Trump's inauguration can continue among the Trump administration's freeze on HHS activities.

Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory viruses, has been named acting director of the nearly $50 billion agency.

The sudden policy change is that the NIH is to cap indirect cost recovery at 15 percent of the direct costs of a grant, ...

Advisory council and scientific review meetings associated with the NIH's grant making process, in which outside scientists provide a final grant review and strategic advice before the finalization of ...

The Department of Government Efficiency held marathon meetings with employees of the National Institutes of Health Sunday in ...

Cuts to administrative costs associated with NIH grants could jeopardize the economic well-being of cities dependent on ...

A federal judge issued a temporary restraining order against the National Institutes of Health, marking the latest successful ...